In a patient with cerebellar symptoms and high anti‑RNP antibodies but a normal brain MRI, what is the recommended management?

Proceed with comprehensive autoimmune cerebellar ataxia workup and initiate immunotherapy promptly

In a patient with cerebellar symptoms and elevated anti-RNP antibodies but normal brain MRI, you should immediately test for neuronal autoantibodies in both serum and CSF, perform lumbar puncture to assess for inflammatory markers, and initiate immunotherapy with high-dose corticosteroids once infection is ruled out—a normal MRI does not exclude autoimmune cerebellar ataxia (ACA). 1, 2

Why Normal MRI Doesn't Rule Out Autoimmune Disease

A normal brain MRI is common in early autoimmune cerebellar ataxia and should not delay diagnosis or treatment. Recent case series demonstrate that:

• 30-50% of ACA patients have normal initial MRI despite active cerebellar symptoms 2, 3
• MRI abnormalities (cerebellar atrophy, white matter changes) often appear later in the disease course 2, 4
• Normal imaging at presentation does not predict treatment response or exclude immune-mediated disease 5, 6

Essential Diagnostic Workup

Immediate Testing Required:

Cerebrospinal Fluid Analysis:

• Cell count and differential (look for lymphocytic pleocytosis)
• Protein levels (elevated in ~67% of ACA cases) 2
• Oligoclonal bands and IgG index/synthesis rate 1
• Neuronal autoantibodies in CSF (critical—serum alone misses cases) 1, 3

Comprehensive Autoantibody Panel: Test both serum AND CSF for:

• Anti-GAD (most common in ACA) 2
• Anti-Tr, anti-mGluR1, anti-Homer-3, anti-NCDN 5, 2, 4
• Anti-mGluR2, anti-ITPR1, anti-Zic4 3
• Note: Some antibodies appear only in serum, others only in CSF 3, 4

Additional Studies:

• EEG if any altered mental status or seizure-like activity 1
• Consider FDG-PET if clinical suspicion remains high despite negative initial workup 1

Cancer Screening Protocol

Given the association between cerebellar syndromes and malignancy:

• CT chest/abdomen/pelvis with contrast (mandatory initial screening) 1
• Add mammogram/breast MRI and pelvic ultrasound in women 1
• Consider whole-body FDG-PET if initial screening negative 1
• Screen for small-cell lung cancer and breast cancer particularly 7, 8

Treatment Algorithm

First-Line Immunotherapy (Start Immediately After Ruling Out Infection):

High-dose IV methylprednisolone is the preferred initial treatment 1, 5:

• 1000 mg daily for 3-5 days
• Follow with oral prednisone taper 1

Alternative if steroids contraindicated:

• IVIG (preferred if patient agitated or has bleeding disorder) 1
• Plasma exchange (preferred if severe hyponatremia or high thrombotic risk) 1

Escalation Strategy:

If no improvement after 2-4 weeks of first-line therapy:

• Add IVIG or plasma exchange to steroids 1, 5
• Consider combination therapy from the start if severe presentation 1

If no improvement after combined acute therapy:

• Rituximab for antibody-mediated disease (most ACA cases) 1, 4, 6
• Cyclophosphamide for suspected cell-mediated disease 1
• Mycophenolate mofetil for maintenance 4

Critical Pitfalls to Avoid

Don't wait for MRI abnormalities to treat: Cerebellar atrophy on MRI often indicates irreversible damage and correlates with poor prognosis 4, 6. Early treatment before structural changes appear is essential.

Don't test serum antibodies alone: Multiple case reports show antibodies present only in CSF or only in serum 3, 4. Both compartments must be tested.

Don't assume anti-RNP alone explains cerebellar symptoms: While anti-RNP is associated with NPSLE, specific neuronal antibodies are more directly linked to cerebellar syndromes 9. The diagnostic approach should parallel autoimmune encephalitis protocols 1.

Don't delay immunotherapy pending antibody results: If clinical suspicion is high and infection excluded, start treatment empirically 1, 5. Waiting for antibody results (which can take weeks) worsens outcomes.

Prognosis Considerations

• Early immunotherapy significantly improves outcomes 5, 2
• Patients with Homer-3 antibodies may have suboptimal steroid response and require more aggressive therapy 4, 6
• Relapse occurs in ~30% of cases, particularly during steroid taper 6
• Maintain low-dose oral corticosteroids for 6-12 months to prevent relapse 5

The key message: Normal brain MRI in the setting of cerebellar symptoms and positive autoantibodies requires the same aggressive diagnostic and therapeutic approach as if the MRI were abnormal—time to treatment initiation is the most modifiable prognostic factor. 5, 2